PMDA
- Application: Zafatek
- Local brand name: Zafatek
- Status: approved
🇯🇵 TRELAGLIPTIN SUCCINATE in Japan
TRELAGLIPTIN SUCCINATE (TRELAGLIPTIN SUCCINATE) regulatory status in Japan.
Marketing authorisation
TRELAGLIPTIN SUCCINATE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is TRELAGLIPTIN SUCCINATE approved in Japan?
Yes. PMDA has authorised it.
Who is the marketing authorisation holder for TRELAGLIPTIN SUCCINATE in Japan?
Marketing authorisation holder not available in our data.